PHARMAZEUTISCHE DARREICHUNGSFORMEN, WELCHE EINEN TABLETTENKERN MIT EINER BRUCHFESTIGKEIT UNTER 38N/QCM UND EINEN ÜBERZUG ZUM SCHUTZ DES WEICHEN KERNS ENTHALTEN

A pharmaceutical dosage form comprising: a) a tablet core comprising a pharmaceutically active ingredient and one or more pharmaceutically active ingredient and one or more pharmaceutically acceptable adjuvants, the tablet core having a tensile strength of less than 38 N/cm2 before coating and fusio...

Full description

Saved in:
Bibliographic Details
Main Authors WHITEMAN, MARSHALL, LANGRIDGE, JOHN, TIAN, WEI
Format Patent
LanguageGerman
Published 27.12.2007
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:A pharmaceutical dosage form comprising: a) a tablet core comprising a pharmaceutically active ingredient and one or more pharmaceutically active ingredient and one or more pharmaceutically acceptable adjuvants, the tablet core having a tensile strength of less than 38 N/cm2 before coating and fusion and b) a coating extending over at least 25% of the surface area of the tablet core, the coating resulting from deposition of a powder comprising fusible particles and fusing the particles to form a coating film, thereby providing the pharmaceutical dosage form with a greater hardness/crush strength than the tablet core. The tablet core may be formed by light compression with enables coated components and fragile components, such as capsules, to be used within the compression blend with little or no damage.
Bibliography:Application Number: DE20036013296T